Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Quidel Corporation (QDEL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Market reaction Comment Full text

Quidel Corporation (QDEL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Market reaction Comment Full text

Lisata Therapeutics Inc (LSTA)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026

Market reaction Comment Full text

Exicure Inc. (XCUR)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

Market reaction Comment Full text

Ocular Therapeutix Inc (OCUL)

  • Business News
  • Jan. 21, 2026, 12:00 UTC
  • 1
  • 1 comments

Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Jan. 21, 2026, 11:21 UTC
  • 1
  • 1 comments

Johnson & Johnson - Johnson & Johnson reports Q4 and Full-Year 2025 results

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Jan. 21, 2026, 11:20 UTC
  • 1
  • 1 comments

Johnson & Johnson reports Q4 and Full-Year 2025 results

Market reaction Comment Full text

Portage Biotech Inc. (PRTG)

  • SEC News
  • Jan. 21, 2026, 11:17 UTC
  • 5
  • 0 comments

New Form 6-K/A - AlphaTON Capital Corp Filed: 2026-01-21 AccNo: 0001171843-26-000354 Size: 6 MB

Comment Full text

IO Biotech Inc. (IOBT)

  • SEC News
  • Jan. 21, 2026, 11:05 UTC
  • 0
  • 1 comments

(99% Neutral) IO Biotech Inc. (IOBT) Announces Business Combination

Comment Full text

Daxor Corporation (DXR)

  • SEC News
  • Jan. 21, 2026, 11:05 UTC
  • 7
  • 0 comments

New Form EFFECT - DAXOR CORP Filed: 2026-01-20 AccNo: 9999999995-26-000211 Size: 1 KB

Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • SEC News
  • Jan. 21, 2026, 11:05 UTC
  • 4
  • 0 comments

New Form EFFECT - Avalo Therapeutics, Inc. Filed: 2026-01-20 AccNo: 9999999995-26-000222 Size: 1 KB

Comment Full text

Natera Inc (NTRA)

  • Business News
  • Jan. 21, 2026, 11:00 UTC
  • 1
  • 1 comments

Natera - Natera Publishes Clinical Validation ofLatitude™ Tissue-Free MRD Test in Colorectal Cancer

Market reaction Comment Full text

Medi Lifestyle Limited (Z4D)

  • SEC News
  • Jan. 21, 2026, 10:41 UTC
  • 6
  • 0 comments

General Announcement: Minutes of Extraordinary General Meeting held on 22 December 2025

Comment Full text

IO Biotech Inc. (IOBT)

  • Business News
  • Jan. 21, 2026, 10:30 UTC
  • 1
  • 1 comments

IO Biotech, Inc. - IO Biotech Announces Exploration of Strategic Alternatives

Market reaction Comment Full text
  • Previous
  • 86
  • 87
  • 88
  • 89
  • 90
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2238)
  • SEC News(188884)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124453)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin